Statera BioPharma Inc (STAB)

[mick]

Panacela


Panacela Labs, Inc. is a joint venture company founded in 2011 by Cleveland BioLabs and Open Joint Stock Company "Rusnano", a $7 billion Russian Federation fund, in conjunction with Roswell Park Cancer Institute, Children’s Cancer Institute Australia and Cleveland Clinic Foundation. Panacela is 60.47% owned by Cleveland BioLabs.

Rusnano's mission is to develop the Russian nanotechnology industry through co-investment in nanotechnology projects with substantial economic potential or social benefit. The Government of the Russian Federation owns 100 percent of the shares in Rusnano. Anatoly Chubais is chairman of the Executive Board of Rusnano.

Panacela’s lead product candidate is Mobilan.

Mobilan - Adenovirus-based cancer treatment inducing immune response
To learn more about Panacela Labs, Inc., please visit the company's website at http://www.panacelalabs.com.

http://www.cbiolabs.com/panacela